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An immunoabsorbent column was made with antibody to trypsinized human C5. This 
column removed the chemotactic activity from zymosan-activated serum as well as from 
C5a des-arg-enriched fractions. Anti-trypsinized C5-absorbed human serum was sub- 
stituted for unabsorbed human serum in the chemotaxis under agarose system. This 
resulted in significantly reduced random neutrophil migration with a negligible effect 
on C5a des-arg or FMLP-directed migration. The results indicate that much of the random 
migration observed in the chemotaxis under agarose system is due to C5derived peptides 
present in normal human serum. 
INTRODUCTION 
Leukocytes from several species migrate under agarose in either a random 
or directed manner, the latter response being to a chemotactic gradient. 
Since its description by Cutler (1974), multiple variations of this technique 
have been described (Nelson et al., 1975; Repo, 1977; Chenoweth et al., 
1979; Rabinovitch et al., 1980; Tannous and Cavender, 1980). The major 
advantages of the migration under agarose method include: simplicity, 
requirement of small leukocyte numbers and microliter volumes of reagents, 
and the ability to assess both random and directed migration in the same 
population of cells. 
The agarose chemotaxis system requires the presence of serum or albumin 
(Cutler, 1974; Nelson et al., 1975; Repo, 1977) or gelatin (Chenoweth et al., 
1979). Although the use of serum in agarose provides a more physiological 
milieu, serum is known to contain both cytotaxins and inhibitors of leuko- 
1 Supported in part, by NIH Grants AICA 17334 and GM 28499-01. 
Abbreviations: FMLP, N-formyl-L-methionyl+leucyl-L-phenylalanine; E-MEM, Minimum 
Essential Medium with Earle’s salts; HINHS, heat-inactivated normal human AB serum; 
HIZAS, heat-inactivated zymosan-activated normal human AB serum; S-anti-trypC5, 
Sepharose GB-anti-trypsinized C5; CI, chemotactic index. 
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cyte migration. In addition, various serum pools might contain different 
quantities of these effectors which can lead to a lack of reproducibility 
among different serum pools (Nelson et al., 1975). 
Coagulation has long been recognized as a means of generating cytotaxins 
(Kaplan et al., 1972). Wiggins and Giclas (1980) have recently reported that 
the incubation of highly purified rabbit kallikrein with complement com- 
ponent C5 generated chemotactic peptides. The data presented in this paper 
demonstrate that absorption of heat-inactivated normal human serum with 
Sepharose-anti-trypsinized C5 prior to its incorporation into agarose signifi- 
cantly reduced random leukocyte migration without significantly affecting 
C5a des-arg- or FMLP<lirected migration. Immunoabsorption of serum with 
antibody to C5 chemotactic peptides results in increased chemotactic indices 
as well as greater reproducibility among different serum pools. 
MATERIALS AND METHODS 
Preparation o f  human leukocytes 
Blood from healthy volunteers was drawn into disposable syringes con- 
taining 100 U of preservative-free sodium heparin/ml of blood. Erythrocytes 
were sedimented by gravity following the addition of 1 ml of 6% Dextran 
T 70 (Pharmacia Fine Chemicals, Piscataway, NJ) (w/v) in physiological 
saline to 3 ml of blood. The leukocyte-rich plasma was centrifuged at 
150 × g for 10 min, the cells washed twice in E-MEM (Grand Island Biologi- 
cal Co., Grand Island, NY) and residual erythrocytes removed by hypotonic 
lysis. The leukocyte suspension routinely contained 50--85% neutrophils 
and was >97% viable as determined with acridine orange, ethidium bromide 
fluorescence (Lee et al., 1975). Leukocytes were suspended in E-MEM sup- 
plemented with 100U/ml penicillin, 100 pg/ml streptomycin, 20 mM 
HEPES buffer, 2.2 mg/ml NaHCO3 to contain 2.5 × 107 neutrophils/ml. 
Preparation o f  serum 
Blood from AB donors was allowed to clot at 37°C for 30 min followed 
by 90 min at 4°C. Serum was collected after centrifugation at 800 × g for 30 
min and lipids removed by ultracentrifugation (100,000 ×g)  for 1 h. Fol- 
lowing heat inactivation (56°C for 30 min) the serum, designated HINHS, 
was passed through 0.45 t~m filters (Nalge Co., Rochester, NY) and stored in 
small aliquots at --80°C until used. 
Alternately, AB plasma was obtained from a local blood bank and con- 
vetted into serum by adding CaC12 to 10 mM and 2 U/ml thrombin (Parke- 
Davis, Moris Plains, NJ) and incubated for 18 h at 4°C. Serum was freed of 
clots by passage through cheesecloth and ultracentrifuged at 100,000 × g to 
remove lipids. The serum was heat-inactivated, filtered and stored as 
described above. 
Absorption o f  serum with S-anti-tryp-C5 
Complement component C5 was digested with trypsin as previously 
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described (Ward and Newman, 1969). Antibodies to trypsinized C5 were 
raised in goats and the serum IgG was isolated according to the method of  
Gray et al. (1969). Reactivity of  IgG anti-trypsinized C5 with highly purified 
C5a isolated, as described by Vallota and Miiller-Eberhard (1973),  was 
demonstrated by immunodiffusion.  
Five mg/ml of  t h e  IgG fraction of  anti-trypsinized C5 were coupled to 
Sepharose 6B (Pharmacia Fine Chemicals) following cyanogen bromide 
activation (Cuatrecasas et al., 1968) and is referred to as S-anti-tryp-C5. Two 
volumes of  HINHS were incubated with 0.5 vol of  packed S-anti-tryp-C5 for 
30 min at 4°C after which the latter was removed by  centrifugation (400 X g 
for 10 min). The S~anti-tryp-C5-absorbed serum was stored at --80°C until 
used. Alternately, HINHS was passed over a column containing S-anti-tryp- 
C5 with the same results. As a control, HINHS was absorbed with uncon- 
jugated Sepharose 6B. 
Preparation of agarose plates 
Agarose plates for chemotaxis were made as described by  Nelson et al. 
(1975) with minor modifications. In brief, a 5 ml mixture of  1% agarose 
(Seakem, Marine Colloids, Rockland, ME) in supplemented E-MEM con- 
taining 10% HINHS or 10% S-anti-tryp-C5-absorbed HINHS was added to 
each 60 mm X 15 mm tissue culture dish (Falcon, Oxnard, CA). Six series of  
3 wells 3 mm in diameter and spaced 3 mm apart were cut  in each plate with 
a plexiglass template and stainless steel punch. 
Chemotactie factors 
Fresh human AB serum was activated with 10 mg/ml zymosan (Sigma 
Chemical Co., St. Louis, MO) for 60 min at 37°C. The zymosan was removed 
by centrifugation and the serum inactivated for 30 min at 56 ° C. The resulting 
HIZAS was passed over S-anti-tryp-C5 columns and a C5a des-arg-enriched 
fraction was eluted with 0.2 M glycine HC1 buffered saline pH 2.8. Following 
dialysis vs. PBS, the C5a des-arg-enriched fraction was passed over Sephadex 
G-75 (Pharmacia Fine Chemicals) and the resultant fractions were assayed in 
the agarose chemotaxis system for chemotactic activity. Active fractions, 
found only in the 10,000--15,000 Mr range, were pooled and titrated for 
chemotactic  activity. A dilution in E-MEM giving optimal activity was sub- 
sequently used in chemotaxis assays. N-formyl-L-methionyl-L-leucyl-L- 
phenylalanine (FMLP) was purchased from Vega Biochemicals (Tucson, AZ). 
Stock solutions, 10 -3 M in DMSO, were diluted to 10 -7 M in supplemented 
E-MEM for chemotaxis assays. 
Chemotaxis assays 
Ten microliters of  chemotactic  factor were added to the outer  wells, 
10 pl of  E-MEM to the inner wells, and 10 pl of  leukocyte  suspensions con- 
taining 2.5 X l 0  s neutrophils to the central wells of  agarose plates. After 
incubating at 37°C for various lengths of  t ime in humidified 5% C O J 9 5 %  
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air, the cells were fixed, stained, and their migration quanti tated as described 
by  Nelson et al. (1975). Chemotactic indices were determined by calculating 
the ratio between the mean migration distances toward either C5a des-arg or 
FMLP and those toward E-MEM (Nelson et al., 1975). 
R E S U L T S  
Abrogation of  C5a des-arg-directed migration by S-anti-tryp-C5 
The ability of  S-anti-tryp-C5 to absorb chemotact ic  complement  factors 
from human serum was assessed. The chemoattractants  HIZAS and C5a des- 
arg were absorbed with either S-anti-tryp-C5 or control Sepharose prior to 
their addition to the outer  wells of  1% agarose plates containing 10% HINHS 
simultaneously with the application of  neutrophils to the central wells. The 
plates were incubated at 37°C for 2 h, the cells fixed and stained, and migra- 
t ion distances measured. As shown on Table 1, absorption of  HIZAS or C5a 
des-arg with unconjugated Sepharose had no effect  on their chemotact ic  
properties. After absorption with S-anti-tryp-C5, however, neither HIZAS 
nor C5a des-arg was capable of  inducing neutrophil  migration farther than 
that elicited by  random migration toward E-MEM or HINHS. 
Effect o f  preabsorbing HINHS with S-anti-tryp-C5 on random neutrophil 
m igra tion 
Random migration of  human neutrophils was assessed in 1% agarose con- 
taining either 10% HINHS or 10% S-anti-tryp-C5-absorbed HINHS. E-MEM 
was added to the inner and outer  wells simultaneously with the application 
of  leukocytes  containing 2.5 X l 0  s neutrophils to the central wells of  the 
T A B L E  1 
A b r o g a t i o n  o f  C5a des-arg c h e m o t a c t i c  ac t iv i ty  b y  Sepharose -an t i - t ryps in ized  C5 a f f in i ty  
c o l u m n s  a. 
A t t r a c t a n t  Migra t ion  ( p m )  
( m e a n  -+ S.D. 
of  t r ip l ica te  samples)  
HINHS 580 -+ 45  
H I Z A S  1615  -+ 155 
H I Z A S  passed over  Sepha rose -con t ro l  co l um ns  1580  -+ 125 
H I Z A S  passed over  Sepharose -an t i - t ryps in ized  C5 co l umns  530  -+ 50 
E-MEM 520 4- 80  
C5a des-arg 1710  -+ 190  
C5a des-arg passed over  Sepha rose -con t ro l  c o l u m n s  1680  4- 115 
C5a des-arg passed over  Sepharose -an t i - t ryps in ized  C5 co lumns  530  -+ 35 
a Ten  mic ro l i t e r s  o f  a t t r a c t a n t  were added  to the  o u t e r  wells of  1% agarose p la tes  con-  
t a in ing  10% HINHS s imu l t aneous ly  w i th  t he  app l i ca t ion  o f  2.5 x l 0  s n e u t r o p h i l s  to  the  
cen t ra l  wells. Migra t ion  d is tances  were measu red  a f te r  a 2 h i n c u b a t i o n  at  37°C.  
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agarose plates. After incubating at 37°C for various lengths of time, the cells 
were fixed, stained, and their migration distances were measured. As a 
representative experiment depicted in Fig. 1 demonstrates, random migra- 
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Fig. 1. Time-dependent random neutrophil migration under agarose. E-MEM was added to 
the inner and outer wells simultaneously with the application of teukocytes containing 
2.5 x l 0  s neutrophils to the central wells of  1% agarose containing 10% HINHS 
(s  ; )  or 10% S-anti-tryp-C5-absorbed HINHS (o o). Each point represents 
the mean value obtained from quadruplicate determinations with S.D. < 10% from a 
representative experiment. 
absorbed HINHS-containing plates. At all time intervals examined, however, 
random neutrophil migration in the latter was consistently less than half that 
observed in the former. Characteristic migration patterns achieved after 2 h 
of incubation are shown in Fig. 2. 
Effect o f  preabsorbing HINHS with S-anti-tryp-C5 on C5a des-arg or FMLP- 
directed neutrophil migration 
In the  next series of experiments, C5a des-arg or FMLP was added to the 
outer wells, E-MEM to the inner wells and 2.5 X l0  s neutrophils to the cen- 
tral wells of 1% agarose plates containing 10% HINHS or 10% S-anti-tryp-C5- 
absorbed HINHS. Fig. 3A depicts the migration distances toward C5a des-arg 
when this reagent was added simultaneously with the application of leuko- 
cytes to the above plates. In both systems, migration to C5a des-arg after 30 
min incubation was no greater than  random migration distances (compare 
with Fig. 1). During the next 90 min, however, migration to C5a des-arg 
increased almost linearly with time in both HINHS- and S-anti-tryp-C5- 
absorbed HINHS-containing agarose. At all time intervals examined, greater 
migration distances were observed in the agarose-containing HINHS. When 
FMLP was substituted for C5a des-arg in the above experiments, directed 
migration was observed as early as 30 min after the application of leukocytes 
in both HINHS- and S-anti-tryp-C5-absorbed HINHS-containing agarose (Fig. 
3B). At each time interval almost identical migration distances were attained 
in both agarose systems. 
2 8 8  
The chemotactic response of  neutrophils under agarose in related to a 
concentration gradient that is established by radial diffusion of  the stimulus 
factor from the site of  application (Nelson et al., 1975; Repo, 1977) .  Cells 
migrating spontaneously toward the well containing the chemotactic factor 
Q 
b 
Fig. 2. Characteristic patterns of  random human neutrophil migration under agarose after 
a 2 h incubation at 37°C observed at 15 X magnification. A: random migration in 1% 
agarose containing 10% HINHS. B: random migration in 1% agaxose containing 10% 
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Fig. 3. Time-dependent neutrophil  migration toward C5a des-arg or FMLP in 1% agarose 
containing either 10% HINHS or 10% anti-trypsinized C5-absorbed HINHS. A: migration 
toward C5a des-arg in agarose containing 10% HINHS (e v,) or 107o S-anti-tryp-C5- 
absorbed HINHS (c ©). Leukocytes were added to the central wells simultaneously 
with the application of C5a des-arg to the outer  wells. B: same as A except FMLP was 
substituted for C5a des-arg. C: same as A except C5a des-arg was added 1 h prior to the 
application of leukocytes.  Each data point  represents the mean values of quadruplicate 
samples with S.D. ~< 10% from a representative experiment.  
enter the concentration gradient and move toward its source. Due to its 
larger size, C5a des-arg diffuses less rapidly in agarose than does FMLP (Repo 
and Kosunen, 1977). Since neutrophils randomly migrate faster in agarose- 
containing HINHS (Fig. 1), they would presumably enter into the developing 
C5a des-arg gradient earlier than cells migrating in agarose-containing S-anti- 
tryp-C5-absorbed HINHS. This would explain the larger migration distances 
at all time intervals observed in the former (Fig. 3A). 
The above experiments were repeated permitting C5a des~rg to diffuse 
into the agarose for 1 h prior to the application of leukocytes. As shown in 
Fig. 3C, C5a des-arg-directed migration was now observed as early as 30 min 
after the application of cells in bo th  HINHS- and S-anti-tryp-C5-absorbed 
HINHS-containing agarose. More importantly, C5a des-arg<lirected migration 
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Fig. 4. Characteristic patterns o f  human neutrophil migration after 2 h incubation under 
agarose containing 10% HINHS or 10% anti-trypsinized CS-absorbed HINHS, visualized at 
15 × magnification. A: migration toward CSa des-arg (corresponds to the top of  the 
photo)  or E-MEM (corresponds to the bottom of  the photo) in agarose containing 10% 
HINHS. B: same as A except 10% S-anti-tryp-C5-absorbed HINHS was substituted for 
HINHS. C: migration toward FMLP (corresponds to the top of  the photo) or E-MEM 
(corresponds to the bot tom of  the photo) in agarose containing 10% HINHS. D: same as 
C except 10% S-anti-tryp-C5-absorbed HINHS was substituted for HINHS. 
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distances were approximately the same at each examined time interval in 
both systems. The migration patterns to C5a des-arg, FMLP, and the cor- 







Comparison of  C5a des-arg and FMLP chemotactic indices in agarose.con- 
taining HINHS or S-anti-tryp-C5-absorbed HINHS 
Chemotactic indices (CI) were calculated by dividing the linear distances 
the neutrophils moved from the margin of  the cell well toward either C5a 
Fig. 4C. 
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des-arg or FMLP by the random migration distances to E-MEM (Nelson et al., 
1975). As shown in Fig. 5, CI to both C5a des-arg and FMLP were con- 
sistently higher in agarose containing S-anti-tryp-C5-absorbed HINHS. In the 
case of  C5a des-arg (Fig. 5A, C), CI of  up to 6.8 were achieved in the latter 
w 
Fig. 4D. 
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Fig. 5. Chemotactic indices as a function of time. A: C5a des-arg-was added to the outer 
wells simultaneously with the application of leukocytes containing 2.5 x 10 s neutrophils 
in 1% agarose plates containing 10% HINHS (¢. ¢.) or 10% Sepharose anti-tryp- 
sinized C5-absorbed HINHS (c o). B: same as A except 10 -7 M FMLP was sub- 
stituted for C5a des-arg. C: same as A except C5a des-arg was added 1 h prior to the 
application of  leukocytes. Each point represents mean values obtained from quadrupli- 
cate samples with S.D. < 12%. 
system compared to maximal CI of  2.5 in agarose containing unabsorbed 
HINHS. Similar results were obtained when CI to  FMLP were assessed (Fig. 
5B). Maximum CI in agarose-containing HINHS or S-anti-tryp-C5-absorbed 
HINHS were approximately 3 and 7, respectively. 
Reduction of  random neutrophil migration in agarose containing serum from 
different donor pools 
Pooled normal human AB serum was obtained from a local blood bank, 
converted into serum, and heat-inactivated as described in Materials and 
Methods. Neutrophils were allowed to randomly migrate toward E-MEM for 
2 h in 1% agarose containing 10% serum from each of  4 donor  pools. As 
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TABLE 2 
Ef fec t  o f  absorp t ion  of  pooled  heat- inact ivated h u m a n  sera with Sepharose-ant i - t ryp-  
sinized C5 on  r a n d o m  h u m a n  neut rophi l  migrat ion under  agarose a. 
HINHS added  T r e a t m e n t  R a n d o m  migra t ion  ( in / lm ,  mean  + S.D. 
to  agarose f rom tr ipl icate samples)  
Pool  I Unabsorbed  420 -+ 70 
Absorbed  170 -+ 30 
Pool  2 Unabsorbed  810 -+ 50 
Absorbed  220 -+ 20 
Pool 3 Unabsorbed  580 -+ 55 
Absorbed  150 + 30 
Pool 4 Unabso rbed  510 + 60 
Absorbed  250 -+ 35 
a Ten microl i ters  o f  E-MEM were added  to bo th  the inner and ou te r  wells o f  1% agarose 
plates  conta in ing  10% S-ant i - t ryp-C5-absorbed or unabso rbed  HINHS. Leukocy te s  con- 
taining 2.5 X l 0  s neu t rophi l s  were added  to the  central  wells and r an d o m migra t ion  
assessed af ter  2 h incuba t ion  at 37°C. 
shown in Table 2, the random migration among these pools ranged from 430 
to 810 ;zm. 
The above experiment was repeated after absorbing serum from each of  
the 4 donor  pools with S-anti-tryp-C5 prior to their incorporation into agarose. 
As shown in Table 2, random neutrophil  migration was strikingly reduced 
and ranged from 150 to 250 pm among the 4 pools. 
DISCUSSION 
Several cell types  including polymorphonuclear  leukocytes are capable of  
migrating spontaneously.  Chemotactic factors are thought  to influence this 
locomot ion  in at least two different ways. These factors may stimulate 
random migration, or if properly applied, directed migration (chemotaxis). 
The use of  the migration under agarose method for the assessment of  
chemotaxis is based on the assumption that  chemotactic  factors diffuse from 
the at tractant  wells into the surrounding agarose. This results in the estab- 
lishment of  a chemotact ic  gradient extending from the at tractant  wells 
toward the wells containing cells. Leukocytes  will migrate in such a milieu 
toward the source of  attractant.  One problem associated with the use of  
serum in the agarose system is that  heat stable factors with chemotact ic  
properties have been shown to occur in serum (Stetcher et al., 1971). The 
presence of  such factors, uniformly distributed in agarose, can enhance 
random neutrophil  migration. 
In this report  we describe a modification of  the migration under agarose 
method which substitutes Sepharose-anti-trypsinized C5-absorbed HINHS 
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for HINHS in agarose. This modification consistently reduced random neu- 
trophil migration by at least 50% without significantly affecting C5a des-arg- 
ot  FMLP<lirected migration. In addition, this modification diminished the 
range of random migration distances induced by different serum pools. A 
further advantage of this modification is its simplicity. Two hundred ml of 
Sepharose-anti-trypsinized C5 have been used to absorb up to 1 liter of 
human serum at a time. After use, the conjugate can be washed with 0.1 M 
glycine HC1 buffered saline (pH 2.8) and recycled repeatedly. 
That Sepharose-anti-trypsinized C5 effectively absorbs C5<lerived 
chemotactic activity from human serum is shown on Table 1. Following 
absorption with this conjugate, both HIZAS and C5a des-arg were no longer 
capable of inducing directed neutrophil migration. The absorbed chemo- 
tactic activity was recovered from the conjugate with 0.2 M glycine HC1 buf- 
fered saline and could subsequently be utilized in chemotactic assays. This 
implies that absorption from normal serum of C5~lerived chemotactic 
peptides or other chemotactic factors cross-reacting antigenically with C5- 
derived factors accounts for the substantial reduction in random neutrophil 
migration. 
Taken together, C5a and C5a des-arg (the des-arg 74 derivative of C5a) are 
considered to be the most potent  and physiologically important  of the 
known chemotactic factors (Fernandez et al., 1978; Henson et al., 1978). 
Complement  C5<lependent chemotactic activity may be generated by the 
action of neutrophil (Ward and Hill, 1970; Goldstein and Weissmann, 1974) 
and platelet (Weksler and Coupal, 1973) granule-associated enzymes. 
Mechanical forces generated during clot formation can damage these blood 
cells causing them to release their chemotactic factors into the serum. 
Interactions between the complement system and coagulation pathways 
resulting in chemotactic activity have been documented.  The action of 
thrombin on fibrinogen resulting in clot formation, for example, generates 
chemotactic activity (Kay et al., 1973). Activation of Hageman factor gener- 
ates chemotactic activity by triggering intrinsic coagulation, fibrinolytic, and 
kinin generating pathways (Kay and Kaplan, 1975). It has recently been 
demonstrated that a 28,000 Mr fragment from activated Hageman factor 
activates several complement  components including C5 (Ghebrehiwet et al., 
1981). Activated Hageman factor converts prekallikrein to kaUikrein which, 
in turn, has been shown to cleave C5 and generate chemotactic peptides 
(Wiggins and Giclas, 1980). The chemotactic activity produced by these 
mechanisms under physiological conditions, however, is very low compared 
to that generated in serum by agents known to activate the classical or alter- 
nate complement  pathways (Weiss et al., 1974). In support of this finding is 
the observation in the agarose system that  HINHS exhibits very little chemo- 
tactic activity compared to HIZAS (Table 1; Nelson et al., 1975). 
A major question raised by the data presented in this report is to what 
extent complement<lerived chemotactic activity in HINHS is generated dur- 
ing the coUection'of serum or plasma and how much of it is present in the 
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circulation of  normal blood donors.  Weisdorf et al. (1980) have found that  
C5a infused into rabbits is cleared f rom the vascular system exponent ia l ly  
with a half-life of  3 min. There are several known physiological mechanisms 
which are capable of  inactivating chemotact ic  factors. Normal human serum 
contains chemotact ic  factor  inactivators which degrade both  complement-  
derived and bacterial chemoat t rac tants  (Berenberg and Ward, 1973; Till and 
Ward, 1975; Ward and Ozols, 1976). Neutrophil  granule lysates contain 
proteases which also can inactivate chemotact ic  factors (Ward and Hill, 
1970; Wright and Gallin, 1977). In addition, the myeloperoxidase-hydrogen 
peroxide halide system catalyzes the inactivation of these factors (Clark 
and Klebanoff,  1979).  Recent ly  Chenoweth  and Hugli (1980) have 
presented evidence of  receptors  on the surface of  neutrophils  which specifi- 
cally and irreversibly bind 12SI-labeled C5a. These and other  mechanisms 
might act to maintain negligible levels of  C5-derived chemotact ic  factors in 
the circulation of  healthy individuals. It is reasonable to assume, therefore ,  
that  some, if no t  most, of  the C5-derived chemokinet ic  activity present in 
plasma or serum is generated during the collection of  blood from donors.  
Whatever the source of  the C5-derived activity present in HINHS, its removal 
with S-anti-tryp-C5 substantially reduces random neutrophil  migration and 
allows greater reproducibi l i ty  among serum pools used in chemotaxis  under  
agarose assays. 
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